Amylin Pharmaceuticals, Inc.San Diego, CA United States
Company Description
Amylin Pharmaceuticals helps diabetics gain the upper hand in their battle with the disease. The company makes and markets injectable diabetes drugs Byetta and Symlin, which are approved as adjunct therapies to other diabetes treatments such as metformin and insulin. Byetta is also approved as a stand-alone diabetes therapy. Amylin gained
| 9360 Towne Centre Dr. | Phone: 858-552-2200 | http://www.amylin.com |
| San Diego, CA 92121 | Fax: 858-552-2212 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Amylin Pharmaceuticals, Inc. Rankings
Executives
| 118 executives listed for Amylin Pharmaceuticals, Inc.'s San Diego, CA location. | ||
| Chairman | Paulo Costa | |
|---|---|---|
| President, CEO, and Director | Daniel Bradbury | |
| SVP Operations | Paul Marshall | |
Financials
| Company Type | Public - NASDAQ: AMLN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 1,300 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Amylin Pharmaceuticals, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
